Blood and marrow transplantation for sickle cell disease: Overcoming barriers to success

Current Opinion in Oncology

Volumn 21, Issue 2, 2009, Pages 158-161

  Bolaños Meade, Javier ^a   Brodsky, Robert A ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Division of Hematology   (United States)

Author keywords

Bone marrow transplantation; Haploidentical bone marrow transplant; Sickle cell disease; Umbilical cord transplantation

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CLONAZEPAM; CYCLOPHOSPHAMIDE; FLUDARABINE; HLA ANTIBODY; THYMOCYTE ANTIBODY;

BLOOD DONOR; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; DISEASE FREE SURVIVAL; GRAFT VERSUS HOST REACTION; HAPLOIDY; HUMAN; MULTIPLE CYCLE TREATMENT; NEUROLOGIC DISEASE; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; SIBLING; SICKLE CELL ANEMIA; STEM CELL; UMBILICAL CORD BLOOD;

ANEMIA, SICKLE CELL; BONE MARROW TRANSPLANTATION; CLINICAL TRIALS AS TOPIC; DISEASE-FREE SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; TISSUE DONORS; TRANSPLANTATION CONDITIONING;

EID: 62349100621     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e328324ba04     Document Type: Review

References (19)

1. Walters MC, Patience M, Leisenring W, et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996; 335:426-428.
2. Walters MC, Storb R, Patience M, et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000; 95:1918-1924.
3. Vermylen C, Cornu G, Ferster A, et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant 1998; 22:1-6.
4. Bernaudin F, Socie G1 Kuentz M, et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007; 110:2749-2756. Results of a very large prospective trial on the use of high-dose chemotherapy and BMT in patients with SCD.
5. Chakrabarti S, Bareford D. A survey on patient perception of reduced-intensity transplantation in adults with sickle cell disease. Bone Marrow Transplant 2007; 39:447-451. Brief discussion on the perception of patients with SCD about transplantation. It gives an idea of the toxicities that this group of patients may be willing to tolerate.
6. Johnson FL, Look AT, Gockerman J, et al. Bone-marrow transplantation in a patient with sickle-cell anemia. N Engl J Med 1984; 311:780-783.
7. Panepinto JA, Walters MC, Carreras J, et al. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol 2007; 137:479-485. Report of a large cohort of recipients of BMT for the therapy of SCD.
8. Jacobsohn DA, Duerst R, Tse W, Kletzel M. Reduced intensity haemopoietic stem-cell transplantation for treatment of nonmalignant diseases in children. Lancet 2004; 364:156-162.
9. Horan JT, Liesveld JL, Fenton P, et al. Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit antithymocyte globulin. Bone Marrow Transplant 2005; 35:171-177.
10. Iannone R, Casella JF, Fuchs EJ, et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant 2003; 9:519-528.
11. Horwitz ME, Spasojevic I, Morris A, et al. Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics. Biol Blood Marrow Transplant 2007; 13:1422-1426.
12. Eggleston B, Patience M, Edwards S, et al. Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia. Br J Haematol 2007; 136:673-676. Brief discussion of some of the long-term side effects of transplantation in patients with SCD.
13. Brachet C, Heinrichs C, Tenoutasse S, et al. Children with sickle cell disease: growth and gonadal function after hematopoietic stem cell transplantation. J Pediatr Hematol Oncol 2007; 29:445-450. Brief discussion of some of the long-term side effects of transplantation in patients with SCD.
14. Bernaudin F, Kuentz M, Socie G. Late effects of myeloablative stem cell transplantation or late effects of sickle cell disease itself. Blood 2008; 111:1744. Brief discussion of some of the long-term side effects of transplantation in patients with SCD.
15. Wu CJ, Gladwin M, Tisdale J, et al. Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis. Br J Haematol 2007; 139:504-507. Interesting study showing biologic improvement on hemolysis markers in patients with mixed chimerism.
16. Locatelli F, Rocha V, Reed W, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003; 101:2137-2143.
17. Adamkiewicz TV, Szabolcs P, Haight A, et al. Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience. Pediatr Transplant 2007; 11:641-644. Report of a small group of patients undergoing umbilical cord transplants for SCD.
18. Luznik L, O'Donnell PV, Symons HJ, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2008; 14:641-650.
19. Brodsky RA, Luznik L, Bolanos-Meade J, et al. Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases. Bone Marrow Transplant 2008; 42:523-527. Report of a small series of patients undergoing haploidentical BMTs for non-malignant hematologic conditions, including SCD.